C07AA07 - Sotalol |
Not porphyrinogenic |
NP |
Rationale
Beta-blocker, not metabolised. Occasional clinical observation of tolerance. Two references state non-porphyrinogenicity.
Chemical description
(To be edited, initial data ST OCT 04) Watersoluble beta-receptor blocking substance. Excreted unchanged in urine. Thunell, patient reports (n=3 ): tolerated. South African list: use. French list: authorized. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
© NAPOS 2024